- Home
- RGNX vs CSR Comparison
RGNX vs CSR Comparison
Compare RGNX & CSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGNX | CSR |
|---|---|---|
| Founded | 2008 | 1970 |
| Country | United States | United States |
| Employees | N/A | 349 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 793.5M | 931.7M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | RGNX | CSR |
|---|---|---|
| Price | $7.45 | $57.05 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 9 |
| Target Price | $23.58 | ★ $62.86 |
| AVG Volume (30 Days) | ★ 1.3M | 215.4K |
| Earning Date | 11-09-2026 | 11-02-2026 |
| Dividend Yield | N/A | ★ 5.46% |
| EPS Growth | ★ 18.08 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,393,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $23.50 | N/A |
| P/E Ratio | ★ N/A | $62.27 |
| Revenue Growth | ★ 126.48 | N/A |
| 52 Week Low | $5.46 | $52.00 |
| 52 Week High | $16.19 | $69.61 |
Technical Indicators
Market Signals| Indicator | RGNX | CSR |
|---|---|---|
| Relative Strength Index (RSI) | 50.22 | 53.95 |
| Support Level | $6.96 | $54.01 |
| Resistance Level | $8.31 | $57.63 |
| Average True Range (ATR) | 0.43 | 0.96 |
| MACD | 0.06 | 0.07 |
| Stochastic Oscillator | 55.77 | 55.14 |
Price Performance
Historical ComparisonAbout RGNX REGENXBIO Inc.
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
About CSR D/B/A Centerspace
Centerspace is a real estate investment trust (REIT) that focuses on the ownership, management, acquisitions, redevelopment, and development of apartment communities. The company operates through a single reportable segment which includes the ownership, management, development, redevelopment, and acquisition of apartment communities and conduct their corporate operations from offices in Minot, North Dakota and Minneapolis, Minnesota.